Results 161 to 170 of about 224,404 (241)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

, 2017
Aska Toda, Kenjiro Sawada, Akihiko Yoshimura, Erika Nakatsuka, Hiromasa Kuroda, Katsumi Kozasa, Mayuko Miyamoto, Kae Hashimoto, Seiji Mabuchi, Tadashi Kimura Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita ...
Yoshimura A, Kozasa K, Sawada K, Mabuchi S, Kimura T, Kuroda H, Miyamoto M, Nakatsuka E, Toda A, Hashimoto K   +9 more
core  

The Effect of Bisphosphonate Treatment on Blood Lipid Parameters in Patients with Postmenopausal Osteoporosis

, 2005
Bisphosphonates are currently the most preferred class of drugs used for the treatment of metabolic bone disease such as osteoporosis and Paget’s disease. Although their exact mechanism has not been identified, the compounds containing amino group (amino
Çiğdem Tüzün, Fatma Taneli, Canan Tıkız   +2 more
core  

Estimated prevalence of osteoporosis in postmenopausal women in Saudi Arabia: A multicenter cross-sectional study. [PDF]

Medicine (Baltimore)
Hakim NA, Hussein KS.
europepmc   +1 more source

The "gut-immune-bone axis": quantitative MRI reveals the microbial-immune-bone metabolic interplay in osteoporosis. [PDF]

Front Immunol
Wu L, Yao HY, Fu ZJ, Luo RH, Zhou S.
europepmc   +1 more source

Cost-utility analysis of deep learning-based opportunistic osteoporosis screening using chest radiographs: implications of diagnostic thresholds and confirmatory testing. [PDF]

Arch Osteoporos
Shi BX, Tsai DJ, Lin C, Lin SH, Hsieh PH, Fang WH.   +5 more
europepmc   +1 more source

The FGF23/α-Klotho Axis in Postmenopausal Osteoporosis: Associations with Bone Mineral Density and Diagnostic Discrimination. [PDF]

J Clin Med
Karalok MH, Misirlioglu NF, Akin OD, Uzun H.   +3 more
europepmc   +1 more source

Clinical guidelines for the management of osteoporosis in China: a systematic review. [PDF]

Front Endocrinol (Lausanne)
Wei T, Xu L, Xiong S, Zhang X, Tian M, Yang M, Wang Y, Chen M, Abbott P, Wong PKK, Kolt GS, Si L.   +11 more
europepmc   +1 more source

Pulse wave velocity as a non-invasive discriminative marker of bone health in postmenopausal women. [PDF]

Caspian J Intern Med
Avramovska M, Nikleski Z, Avramovski P, Todorovska L, Talev S, Stefanovska S, Sotiroski K, Zdraveski D.   +7 more
europepmc   +1 more source

Xylosyltransferase-I serum activity is a promising biomarker for postmenopausal osteoporosis. [PDF]

Sci Rep
Witt A, De Martinis M, Kühle M, Schmidt V, Aitella E, Knabbe C, Faust-Hinse I.   +6 more
europepmc   +1 more source

Beyond the T-Score: A Narrative Clinical Review of Adult Endocrine Osteoporosis Care. [PDF]

J Clin Med
Georgescu LM, Igna AD, Popa Tăut EC, Toderaș Herlaș BA, Rațiu IA, Luengo Perez LM, Pașcalău NAM.   +6 more
europepmc   +1 more source